+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Algorithm for resolving discrepancies between claims for smoking cessation pharmacotherapies during pregnancy and smoking status in delivery records: The impact on estimates of utilisation

Algorithm for resolving discrepancies between claims for smoking cessation pharmacotherapies during pregnancy and smoking status in delivery records: The impact on estimates of utilisation

Plos one 13(8): E0202999

The linkage of routine data collections are valuable for population-based evaluation of smoking cessation pharmacotherapy in pregnancy where little is known about the utilisation or safety of these pharmacotherapies antenatally. The use of routine data collections to study smoking cessation pharmacotherapy is limited by disparities among data sources. This study developed an algorithm to resolve disparity between the evidence of pharmacotherapy utilisation for smoking cessation and the recording of smoking in pregnancy, examined its face validity and assessed the implications on estimates of smoking cessation pharmacotherapy utilisation. Perinatal records (n = 1,098,203) of women who gave birth in the Australian States of Western Australia and New South Wales (2004-2012) were linked to hospital admissions and pharmaceutical dispensing data. An algorithm, based on dispensing information about the type of smoking therapy, timing and quantity of supply reclassified certain groups of women as smoking during pregnancy. Face validity of the algorithm was tested by examining the distribution of factors associated with inaccurate recording of smoking status among women that the algorithm classified as misreporting smoking in pregnancy. Rate of utilisation among smokers, according to original and reclassified smoking status, was measured, to demonstrate the utility of the algorithm. Smoking cessation pharmacotherapy were dispensed to 2184 women during pregnancy, of those 1013 women were originally recorded as non-smoking as per perinatal and hospital data. Application of the algorithm reclassified 730 women as smoking during pregnancy. The algorithm satisfied the test of face validity-the expected demographic factors of marriage, private hospital delivery and higher socioeconomic status, were more common in women whom the algorithm identified as misreporting their smoking status. Application of the algorithm resulted in smoking cessation pharmacotherapy utilisation estimates ranging from 2.3-3.6% of all pregnancies. Researchers can use the algorithm presented herein to improve the identification of smoking among women who use cessation pharmacotherapies during pregnancy. Improved identification can improve the validity of safety analyses of smoking cessation pharmacotherapy-providing clinicians with valuable evidence to use when counselling women on the role of pharmacotherapy for smoking cessation during pregnancy.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 065684110

Download citation: RISBibTeXText

PMID: 30161203

DOI: 10.1371/journal.pone.0202999

Related references

Smoking cessation during pregnancy and relapse after childbirth: the impact of the grandmother's smoking status. Maternal and Child Health Journal 12(4): 525-533, 2008

The Emergency Department Action in Smoking Cessation (EDASC) trial: impact on delivery of smoking cessation counseling. Academic Emergency Medicine 19(4): 409-420, 2012

Estimates of smoking before and during pregnancy, and smoking cessation during pregnancy: comparing two population-based data sources. Public Health Reports 128(3): 179-188, 2013

The use of pharmacotherapies for smoking cessation during pregnancy. Tobacco Control 9(Suppl. 3): Iii91-4, 2000

Pharmacotherapies to enhance smoking cessation during pregnancy. Drug and Alcohol Review 22(2): 191-202, 2003

Association of smoking status, cumulative smoking, duration of smoking cessation, age of starting smoking, and depression in Korean adults. Bmc Public Health 12: 724, 2012

Postnatal Cardiovascular Consequences in the Offspring of Pregnant Rats Exposed to Smoking and Smoking Cessation Pharmacotherapies. Reproductive Sciences 24(6): 919-933, 2017

The effect of five smoking cessation pharmacotherapies on smoking cessation milestones. Journal of Consulting and Clinical Psychology 79(1): 34-42, 2011

The Effect of Five Smoking Cessation Pharmacotherapies on Smoking Cessation Milestones. Yearbook of Psychiatry and Applied Mental Health 2012: 155-156, 2012

Identifying Smoking Status and Smoking Cessation Using a Data Linkage Between the Kentucky Cancer Registry and Health Claims Data. Jco Clinical Cancer Informatics 3: 1-8, 2019

How important is the smoking status of the woman's partner as a predictor of smoking cessation in pregnancy? A literature review. Health Education Journal 57(1): 70-80, 1998

Smoking behaviour in pregnancy and its impact on smoking cessation at various intervals during follow-up over 21 years: a prospective cohort study. Bjog 120(3): 288-95; Discussion 296, 2013

The impact of Aboriginal status, cigarette smoking and smoking cessation on perinatal outcomes in South Australia. Medical Journal of Australia 201(5): 274-278, 2014

A bidirectional path analysis model of smoking cessation self-efficacy and concurrent smoking status: impact on abstinence outcomes. Addiction Biology 24(5): 1034-1043, 2019

Looks like smoking, is it smoking?: children's perceptions of cigarette-like nicotine delivery systems, smoking and cessation. Harm Reduction Journal 10: 30, 2013